Sexual Health

closeup of a young caucasian man with a simulated PrEP pill in his hand

PrEP for women: An update for healthcare providers

PrEP use among women has the potential to reduce new HIV infections by 61% (with ≥ 75% adherence), yet less than 10% of men and women who are “behaviorally indicated for PrEP” are utilizing this important prevention tool.

The history of secnidazole

In September 2017, the FDA approved secnidazole for the treatment of bacterial vaginosis. Although new to the United States, secnidazole…

Poll